Glucose-Lowering Medications and Post-Dementia Survival in Patients with Diabetes and Dementia

BACKGROUND: The effectiveness of glucose-lowering drugs (GLDs) is unknown among patients with dementia. OBJECTIVE: To analyze all-cause mortality among users of six GLDs in dementia and dementia-free subjects, respectively. METHODS: This was a longitudinal open-cohort registry-based study using data...

Descripción completa

Detalles Bibliográficos
Autores principales: Secnik, Juraj, Xu, Hong, Schwertner, Emilia, Hammar, Niklas, Alvarsson, Michael, Winblad, Bengt, Eriksdotter, Maria, Garcia-Ptacek, Sara, Religa, Dorota
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028644/
https://www.ncbi.nlm.nih.gov/pubmed/35034902
http://dx.doi.org/10.3233/JAD-215337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028644/
https://www.ncbi.nlm.nih.gov/pubmed/35034902
http://dx.doi.org/10.3233/JAD-215337

Ejemplares similares